ArriVent BioPharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 2.37 M | $47.74 B | 15.97% | 5.66% |
| VANGUARD GROUP INC | 01/29/2026 | 1.87 M | $37.61 M | -7.90% | 4.46% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.70 M | $34.14 M | 0.00% | 4.05% |
| STATE STREET CORP | 02/13/2026 | 1.09 M | $21.97 M | 6.26% | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 753.52 K | $15.16 M | 5.20% | 1.80% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 742.53 K | $14.94 M | 71.91% | 1.77% |
| SC CHINA HOLDING LTD | 02/13/2026 | 663.31 K | $16.72 M | 0.00% | 1.58% |
| 02/05/2026 | 644.79 K | $12.97 B | 100.00% | 1.54% | |
| CITADEL ADVISORS LLC | 02/17/2026 | 458.50 K | $9.23 B | 100.00% | 1.09% |
| UBS GROUP AG | 01/29/2026 | 450.92 K | $9.07 B | -9.38% | 1.08% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 281.95 K | $5.67 M | -1.45% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 250.59 K | $5.04 M | 2.92% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 242.83 K | $4.89 B | 100.00% | 0.58% |
| ROSALIND ADVISORS, INC. | 02/12/2026 | 215.87 K | $4.34 M | 100.00% | 0.52% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 186.49 K | $3.75 M | 45.35% | 0.45% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 150.00 K | $3.02 M | 100.00% | 0.36% |
| BARCLAYS PLC | 02/13/2026 | 129.17 K | $2.60 M | -0.59% | 0.31% |
| JANE STREET GROUP, LLC | 02/12/2026 | 103.26 K | $2.08 B | 100.00% | 0.25% |
| MARSHALL WACE, LLP | 02/13/2026 | 98.98 K | $1.99 M | -45.08% | 0.24% |
| MORGAN STANLEY | 02/13/2026 | 97.59 K | $1.96 M | -75.11% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 77.48 K | $1.56 M | -15.52% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 73.11 K | $1.47 M | 15.53% | 0.17% |
| JPMORGAN CHASE & CO | 02/11/2026 | 69.39 K | $1.40 M | 395.99% | 0.17% |
| MOODY ALDRICH PARTNERS LLC | 01/30/2026 | 56.66 K | $1.14 M | -4.70% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 56.52 K | $1.14 M | 22.93% | 0.13% |
| NUVEEN, LLC | 02/12/2026 | 53.62 K | $1.08 B | 12.49% | 0.13% |
| HRT FINANCIAL LP | 02/12/2026 | 53.42 K | $1.07 M | 100.00% | 0.13% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 51.44 K | $1.04 M | 39.24% | 0.12% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 45.56 K | $916.63 K | 511.19% | 0.11% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 40.30 K | $744.34 K | 100.00% | 0.10% |
| SWISS NATIONAL BANK | 02/12/2026 | 40.00 K | $804.80 K | 12.68% | 0.10% |
| SECTORAL ASSET MANAGEMENT INC | 02/09/2026 | 38.26 K | $769.69 K | -2.50% | 0.09% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 37.10 K | $746.45 K | -15.30% | 0.09% |
| ALPS ADVISORS INC | 02/12/2026 | 33.90 K | $681.99 K | 100.00% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 32.28 K | $649.47 K | 112.66% | 0.08% |
| TEMA ETFS LLC | 01/16/2026 | 32.01 K | $643.98 K | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 02/13/2026 | 31.46 K | $632.89 K | -6.94% | 0.08% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 28.88 K | $581.03 K | -15.96% | 0.07% |
| XTX TOPCO LTD | 02/17/2026 | 26.25 K | $528.21 M | 100.00% | 0.06% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 24.22 K | $487.33 K | 18.73% | 0.06% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 22.12 K | $444.95 K | -20.36% | 0.05% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 21.53 K | $433.20 K | 7.81% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 16.66 K | $335.14 K | -2.65% | 0.04% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 15.28 K | $307.33 K | 3.28% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 14.74 K | $296.63 K | 4.13% | 0.04% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 11.48 K | $230.88 K | -2.94% | 0.03% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/10/2026 | 11.01 K | $221.46 K | 100.00% | 0.03% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 11.01 K | $221.46 K | 0.41% | 0.03% |
| PROFUND ADVISORS LLC | 02/06/2026 | 10.98 K | $221.00 K | 100.00% | 0.03% |
| VIRTUS INVESTMENT ADVISERS, INC. | 02/17/2026 | 10.89 K | $219.19 K | 126.20% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ArriVent BioPharma Inc. institutional Ownership - FAQ's
During the previous two years, 102 institutional investors and hedge funds held shares of ArriVent BioPharma Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 2.37 M
VANGUARD GROUP INC: 1.87 M
Sofinnova Investments, Inc.: 1.7 M
STATE STREET CORP: 1.09 M
GEODE CAPITAL MANAGEMENT, LLC: 753,519
GOLDMAN SACHS GROUP INC: 742,526
31.49% of ArriVent BioPharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.28 M shares in the last 24 months. This purchase volume represents approximately $332.02 M in transactions.